Chuck Royce's TECH Position Overview
Chuck Royce (via Royce & Associates Lp) currently holds 660,034 shares of Bio-Techne Corporation (TECH) worth $36.72 M, representing 0.37% of the portfolio. First purchased in 2014-Q4, this long-term strategic position has been held for 44 quarters.
Based on 13F filings since 2013, Chuck Royce has maintained a long-term strategic position in TECH, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2015, adding 1.25 M shares. Largest reduction occurred in Q1 2015, reducing 841,760 shares.
Analysis based on 13F filings available since 2013 Q2
Chuck Royce's Bio-Techne Corporation (TECH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bio-Techne Corporation (TECH) Trades by Chuck Royce
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2014 | +2.45 M | New Buy | 2.45 M | $23.10 |
| Q1 2015 | -841,760 | Reduce 34.40% | 1.61 M | $25.07 |
| Q2 2015 | +416,296 | Add 25.93% | 2.02 M | $24.62 |
| Q3 2015 | +1.25 M | Add 61.59% | 3.27 M | $23.11 |
| Q4 2015 | +367,160 | Add 11.24% | 3.63 M | $22.50 |
| Q1 2016 | -295,240 | Reduce 8.12% | 3.34 M | $23.63 |
| Q2 2016 | -274,000 | Reduce 8.21% | 3.07 M | $28.19 |
| Q3 2016 | -99,600 | Reduce 3.25% | 2.97 M | $27.38 |
| Q4 2016 | +135,600 | Add 4.57% | 3.1 M | $25.71 |
| Q1 2017 | +118,400 | Add 3.82% | 3.22 M | $25.41 |
| Q2 2017 | -298,000 | Reduce 9.26% | 2.92 M | $29.37 |
| Q3 2017 | -285,400 | Reduce 9.77% | 2.64 M | $30.22 |
| Q4 2017 | -145,132 | Reduce 5.51% | 2.49 M | $32.39 |
| Q1 2018 | -209,484 | Reduce 8.41% | 2.28 M | $37.76 |
| Q2 2018 | -319,200 | Reduce 13.99% | 1.96 M | $36.99 |
| Q3 2018 | -608,812 | Reduce 31.03% | 1.35 M | $51.03 |
| Q4 2018 | -158,052 | Reduce 11.68% | 1.2 M | $36.18 |
| Q1 2019 | -133,600 | Reduce 11.18% | 1.06 M | $49.64 |
| Q2 2019 | -72,140 | Reduce 6.79% | 989,616 | $52.12 |
| Q3 2019 | +51,364 | Add 5.19% | 1.04 M | $48.92 |
| Q4 2019 | -141,572 | Reduce 13.60% | 899,408 | $54.88 |
| Q1 2020 | -7,472 | Reduce 0.83% | 891,936 | $47.40 |
| Q2 2020 | -49,600 | Reduce 5.56% | 842,336 | $66.02 |
| Q3 2020 | +3,532 | Add 0.42% | 845,868 | $61.93 |
| Q4 2020 | -83,524 | Reduce 9.87% | 762,344 | $79.39 |
| Q1 2021 | -41,516 | Reduce 5.45% | 720,828 | $95.48 |
| Q2 2021 | -211,796 | Reduce 29.38% | 509,032 | $112.56 |
| Q3 2021 | -193,396 | Reduce 37.99% | 315,636 | $121.14 |
| Q4 2021 | -9,864 | Reduce 3.13% | 305,772 | $129.33 |
| Q1 2022 | +11,712 | Add 3.83% | 317,484 | $108.26 |
| Q2 2022 | +65,956 | Add 20.77% | 383,440 | $86.66 |
| Q3 2022 | +22,552 | Add 5.88% | 405,992 | $71.00 |
| Q4 2022 | +46,122 | Add 11.36% | 452,114 | $82.88 |
| Q1 2023 | +243,089 | Add 53.77% | 695,203 | $74.19 |
| Q2 2023 | -149,564 | Reduce 21.51% | 545,639 | $81.63 |
| Q3 2023 | +128,646 | Add 23.58% | 674,285 | $68.07 |
| Q4 2023 | +9,185 | Add 1.36% | 683,470 | $77.16 |
| Q1 2024 | +113,094 | Add 16.55% | 796,564 | $70.39 |
| Q2 2024 | +31,538 | Add 3.96% | 828,102 | $71.65 |
| Q3 2024 | +17,296 | Add 2.09% | 845,398 | $79.93 |
| Q4 2024 | +15,353 | Add 1.82% | 860,751 | $72.03 |
| Q1 2025 | +9,434 | Add 1.10% | 870,185 | $58.63 |
| Q2 2025 | +702 | Add 0.08% | 870,887 | $51.45 |
| Q3 2025 | -210,853 | Reduce 24.21% | 660,034 | $55.63 |
Chuck Royce's Bio-Techne Corporation Investment FAQs
Chuck Royce first purchased Bio-Techne Corporation (TECH) in Q4 2014, acquiring 2,447,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Chuck Royce has held Bio-Techne Corporation (TECH) for 44 quarters since Q4 2014.
Chuck Royce's largest addition to Bio-Techne Corporation (TECH) was in Q4 2014, adding 2,447,300 shares worth $56.53 M.
According to the latest 13F filing for Q3 2025, Chuck Royce's firm, Royce & Associates Lp, owns 660,034 shares of Bio-Techne Corporation (TECH), valued at approximately $36.72 M.
As of the Q3 2025 filing, Bio-Techne Corporation (TECH) represents approximately 0.37% of Chuck Royce's publicly disclosed stock portfolio, making it one of their key holdings.
Chuck Royce's peak holding in Bio-Techne Corporation (TECH) was 3,634,276 shares, as reported at the end of Q4 2015.